Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Companies Law, 5759 1999
- 4.3 EX-4.3
- 10.1 Licence Agreement
- 10.2 Execution Copy
- 10.3 Consortium Agreement
- 10.4 Israeli Share Option Plan
- 10.5 Management Services Agreement
- 10.6 Employment Agreement
- 10.7 EX-10.7
- 10.8 Biondvax Pharmaceuticals LTD .
- 10.9 Biondvax
- 10.10 Summary of the Lease Agreement
- 10.11 Addendum to Employment Agreement Dated April 1, 2012, Between Biondvax Pharmaceuticals LTD. and DR. Tamar Ben Yedidia.
- 10.12 Addendum to Service Agreement Dated August 31, 2014, Between Biondvax Pharmaceuticals LTD., CFO Direct and Uri Ben
- 10.13 Employment Agreement Dated August 31, 2014, Between Biondvax Pharmaceuticals LTD. and Uri Ben Or.
- 10.14 Letter of Appointment of Prof. Ethan Rubinstein to Biondvax Pharmaceuticals LTD.'S Scientific Advisory Board Dated January 15, 2004.
- 10.15 Letter of Appointment of Prof. Michel Revel to Biondvax Pharmaceuticals LTD.'S Scientific Advisory Board Dated February 14, 2005.
- 10.16 Letter of Appointment of Prof. Ruth Arnon to Biondvax Pharmaceuticals LTD.'S Scientific Advisory Board Dated February 7, 2005, Together with the Amendment Thereto Dated December 29, 2005.
- 23.1 Consent of Independent Registered Public Accounting Firm
SCNI similar filings
Filing view
External links
Exhibit 4.3